0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Marburgvirus Infection Market Research Report 2023
Published Date: March 2023
|
Report Code: QYRE-Auto-36D6023
Home | Market Reports | Health| Nursing
Global Marburgvirus Infection Market Insights Forecast to 2028
BUY CHAPTERS

Global Marburgvirus Infection Market Research Report 2023

Code: QYRE-Auto-36D6023
Report
March 2023
Pages:92
QYResearch
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Marburgvirus Infection Market

The global Marburgvirus Infection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Marburgvirus Infection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Marburgvirus Infection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Marburgvirus Infection in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Marburgvirus Infection include Arno Therapeutics Inc, BioCryst Pharmaceuticals Inc, Eisai Co Ltd, Emergent BioSolutions Inc, Fab'entech SA, Integrated BioTherapeutics Inc, Johnson & Johnson, NanoViricides Inc and Profectus BioSciences Inc, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Marburgvirus Infection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Marburgvirus Infection.
The Marburgvirus Infection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Marburgvirus Infection market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Marburgvirus Infection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Key Segmentations

By Company

  • Arno Therapeutics Inc
  • BioCryst Pharmaceuticals Inc
  • Eisai Co Ltd
  • Emergent BioSolutions Inc
  • Fab'entech SA
  • Integrated BioTherapeutics Inc
  • Johnson & Johnson
  • NanoViricides Inc
  • Profectus BioSciences Inc
  • Rodos BioTarget GmbH
  • Sarepta Therapeutics Inc
  • Theravectys SA

Segment by Type

  • Eritoran Tetrasodium
  • AR-12
  • ARD-5
  • AVI-7288
  • Others

Segment by Application

  • Hospital
  • Clinic
  • Others

By Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Marburgvirus Infection companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

Scope of Global Marburgvirus Infection Market Report

Report MetricDetails
Report NameGlobal Marburgvirus Infection Market
Base Year2022
Forecasted years2023-2029
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Marburgvirus Infection Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Eritoran Tetrasodium
1.2.3 AR-12
1.2.4 ARD-5
1.2.5 AVI-7288
1.2.6 Others
1.3 Market by Application
1.3.1 Global Marburgvirus Infection Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Marburgvirus Infection Market Perspective (2018-2029)
2.2 Marburgvirus Infection Growth Trends by Region
2.2.1 Global Marburgvirus Infection Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Marburgvirus Infection Historic Market Size by Region (2018-2023)
2.2.3 Marburgvirus Infection Forecasted Market Size by Region (2024-2029)
2.3 Marburgvirus Infection Market Dynamics
2.3.1 Marburgvirus Infection Industry Trends
2.3.2 Marburgvirus Infection Market Drivers
2.3.3 Marburgvirus Infection Market Challenges
2.3.4 Marburgvirus Infection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Marburgvirus Infection Players by Revenue
3.1.1 Global Top Marburgvirus Infection Players by Revenue (2018-2023)
3.1.2 Global Marburgvirus Infection Revenue Market Share by Players (2018-2023)
3.2 Global Marburgvirus Infection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Marburgvirus Infection Revenue
3.4 Global Marburgvirus Infection Market Concentration Ratio
3.4.1 Global Marburgvirus Infection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Marburgvirus Infection Revenue in 2022
3.5 Marburgvirus Infection Key Players Head office and Area Served
3.6 Key Players Marburgvirus Infection Product Solution and Service
3.7 Date of Enter into Marburgvirus Infection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Marburgvirus Infection Breakdown Data by Type
4.1 Global Marburgvirus Infection Historic Market Size by Type (2018-2023)
4.2 Global Marburgvirus Infection Forecasted Market Size by Type (2024-2029)
5 Marburgvirus Infection Breakdown Data by Application
5.1 Global Marburgvirus Infection Historic Market Size by Application (2018-2023)
5.2 Global Marburgvirus Infection Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Marburgvirus Infection Market Size (2018-2029)
6.2 North America Marburgvirus Infection Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Marburgvirus Infection Market Size by Country (2018-2023)
6.4 North America Marburgvirus Infection Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Marburgvirus Infection Market Size (2018-2029)
7.2 Europe Marburgvirus Infection Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Marburgvirus Infection Market Size by Country (2018-2023)
7.4 Europe Marburgvirus Infection Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Marburgvirus Infection Market Size (2018-2029)
8.2 Asia-Pacific Marburgvirus Infection Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Marburgvirus Infection Market Size by Region (2018-2023)
8.4 Asia-Pacific Marburgvirus Infection Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Marburgvirus Infection Market Size (2018-2029)
9.2 Latin America Marburgvirus Infection Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Marburgvirus Infection Market Size by Country (2018-2023)
9.4 Latin America Marburgvirus Infection Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Marburgvirus Infection Market Size (2018-2029)
10.2 Middle East & Africa Marburgvirus Infection Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Marburgvirus Infection Market Size by Country (2018-2023)
10.4 Middle East & Africa Marburgvirus Infection Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Arno Therapeutics Inc
11.1.1 Arno Therapeutics Inc Company Detail
11.1.2 Arno Therapeutics Inc Business Overview
11.1.3 Arno Therapeutics Inc Marburgvirus Infection Introduction
11.1.4 Arno Therapeutics Inc Revenue in Marburgvirus Infection Business (2018-2023)
11.1.5 Arno Therapeutics Inc Recent Development
11.2 BioCryst Pharmaceuticals Inc
11.2.1 BioCryst Pharmaceuticals Inc Company Detail
11.2.2 BioCryst Pharmaceuticals Inc Business Overview
11.2.3 BioCryst Pharmaceuticals Inc Marburgvirus Infection Introduction
11.2.4 BioCryst Pharmaceuticals Inc Revenue in Marburgvirus Infection Business (2018-2023)
11.2.5 BioCryst Pharmaceuticals Inc Recent Development
11.3 Eisai Co Ltd
11.3.1 Eisai Co Ltd Company Detail
11.3.2 Eisai Co Ltd Business Overview
11.3.3 Eisai Co Ltd Marburgvirus Infection Introduction
11.3.4 Eisai Co Ltd Revenue in Marburgvirus Infection Business (2018-2023)
11.3.5 Eisai Co Ltd Recent Development
11.4 Emergent BioSolutions Inc
11.4.1 Emergent BioSolutions Inc Company Detail
11.4.2 Emergent BioSolutions Inc Business Overview
11.4.3 Emergent BioSolutions Inc Marburgvirus Infection Introduction
11.4.4 Emergent BioSolutions Inc Revenue in Marburgvirus Infection Business (2018-2023)
11.4.5 Emergent BioSolutions Inc Recent Development
11.5 Fab'entech SA
11.5.1 Fab'entech SA Company Detail
11.5.2 Fab'entech SA Business Overview
11.5.3 Fab'entech SA Marburgvirus Infection Introduction
11.5.4 Fab'entech SA Revenue in Marburgvirus Infection Business (2018-2023)
11.5.5 Fab'entech SA Recent Development
11.6 Integrated BioTherapeutics Inc
11.6.1 Integrated BioTherapeutics Inc Company Detail
11.6.2 Integrated BioTherapeutics Inc Business Overview
11.6.3 Integrated BioTherapeutics Inc Marburgvirus Infection Introduction
11.6.4 Integrated BioTherapeutics Inc Revenue in Marburgvirus Infection Business (2018-2023)
11.6.5 Integrated BioTherapeutics Inc Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Detail
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Marburgvirus Infection Introduction
11.7.4 Johnson & Johnson Revenue in Marburgvirus Infection Business (2018-2023)
11.7.5 Johnson & Johnson Recent Development
11.8 NanoViricides Inc
11.8.1 NanoViricides Inc Company Detail
11.8.2 NanoViricides Inc Business Overview
11.8.3 NanoViricides Inc Marburgvirus Infection Introduction
11.8.4 NanoViricides Inc Revenue in Marburgvirus Infection Business (2018-2023)
11.8.5 NanoViricides Inc Recent Development
11.9 Profectus BioSciences Inc
11.9.1 Profectus BioSciences Inc Company Detail
11.9.2 Profectus BioSciences Inc Business Overview
11.9.3 Profectus BioSciences Inc Marburgvirus Infection Introduction
11.9.4 Profectus BioSciences Inc Revenue in Marburgvirus Infection Business (2018-2023)
11.9.5 Profectus BioSciences Inc Recent Development
11.10 Rodos BioTarget GmbH
11.10.1 Rodos BioTarget GmbH Company Detail
11.10.2 Rodos BioTarget GmbH Business Overview
11.10.3 Rodos BioTarget GmbH Marburgvirus Infection Introduction
11.10.4 Rodos BioTarget GmbH Revenue in Marburgvirus Infection Business (2018-2023)
11.10.5 Rodos BioTarget GmbH Recent Development
11.11 Sarepta Therapeutics Inc
11.11.1 Sarepta Therapeutics Inc Company Detail
11.11.2 Sarepta Therapeutics Inc Business Overview
11.11.3 Sarepta Therapeutics Inc Marburgvirus Infection Introduction
11.11.4 Sarepta Therapeutics Inc Revenue in Marburgvirus Infection Business (2018-2023)
11.11.5 Sarepta Therapeutics Inc Recent Development
11.12 Theravectys SA
11.12.1 Theravectys SA Company Detail
11.12.2 Theravectys SA Business Overview
11.12.3 Theravectys SA Marburgvirus Infection Introduction
11.12.4 Theravectys SA Revenue in Marburgvirus Infection Business (2018-2023)
11.12.5 Theravectys SA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Marburgvirus Infection Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Eritoran Tetrasodium
    Table 3. Key Players of AR-12
    Table 4. Key Players of ARD-5
    Table 5. Key Players of AVI-7288
    Table 6. Key Players of Others
    Table 7. Global Marburgvirus Infection Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 8. Global Marburgvirus Infection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 9. Global Marburgvirus Infection Market Size by Region (2018-2023) & (US$ Million)
    Table 10. Global Marburgvirus Infection Market Share by Region (2018-2023)
    Table 11. Global Marburgvirus Infection Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 12. Global Marburgvirus Infection Market Share by Region (2024-2029)
    Table 13. Marburgvirus Infection Market Trends
    Table 14. Marburgvirus Infection Market Drivers
    Table 15. Marburgvirus Infection Market Challenges
    Table 16. Marburgvirus Infection Market Restraints
    Table 17. Global Marburgvirus Infection Revenue by Players (2018-2023) & (US$ Million)
    Table 18. Global Marburgvirus Infection Market Share by Players (2018-2023)
    Table 19. Global Top Marburgvirus Infection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Marburgvirus Infection as of 2022)
    Table 20. Ranking of Global Top Marburgvirus Infection Companies by Revenue (US$ Million) in 2022
    Table 21. Global 5 Largest Players Market Share by Marburgvirus Infection Revenue (CR5 and HHI) & (2018-2023)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Marburgvirus Infection Product Solution and Service
    Table 24. Date of Enter into Marburgvirus Infection Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Marburgvirus Infection Market Size by Type (2018-2023) & (US$ Million)
    Table 27. Global Marburgvirus Infection Revenue Market Share by Type (2018-2023)
    Table 28. Global Marburgvirus Infection Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 29. Global Marburgvirus Infection Revenue Market Share by Type (2024-2029)
    Table 30. Global Marburgvirus Infection Market Size by Application (2018-2023) & (US$ Million)
    Table 31. Global Marburgvirus Infection Revenue Market Share by Application (2018-2023)
    Table 32. Global Marburgvirus Infection Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 33. Global Marburgvirus Infection Revenue Market Share by Application (2024-2029)
    Table 34. North America Marburgvirus Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 35. North America Marburgvirus Infection Market Size by Country (2018-2023) & (US$ Million)
    Table 36. North America Marburgvirus Infection Market Size by Country (2024-2029) & (US$ Million)
    Table 37. Europe Marburgvirus Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Europe Marburgvirus Infection Market Size by Country (2018-2023) & (US$ Million)
    Table 39. Europe Marburgvirus Infection Market Size by Country (2024-2029) & (US$ Million)
    Table 40. Asia-Pacific Marburgvirus Infection Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 41. Asia-Pacific Marburgvirus Infection Market Size by Region (2018-2023) & (US$ Million)
    Table 42. Asia-Pacific Marburgvirus Infection Market Size by Region (2024-2029) & (US$ Million)
    Table 43. Latin America Marburgvirus Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. Latin America Marburgvirus Infection Market Size by Country (2018-2023) & (US$ Million)
    Table 45. Latin America Marburgvirus Infection Market Size by Country (2024-2029) & (US$ Million)
    Table 46. Middle East & Africa Marburgvirus Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 47. Middle East & Africa Marburgvirus Infection Market Size by Country (2018-2023) & (US$ Million)
    Table 48. Middle East & Africa Marburgvirus Infection Market Size by Country (2024-2029) & (US$ Million)
    Table 49. Arno Therapeutics Inc Company Detail
    Table 50. Arno Therapeutics Inc Business Overview
    Table 51. Arno Therapeutics Inc Marburgvirus Infection Product
    Table 52. Arno Therapeutics Inc Revenue in Marburgvirus Infection Business (2018-2023) & (US$ Million)
    Table 53. Arno Therapeutics Inc Recent Development
    Table 54. BioCryst Pharmaceuticals Inc Company Detail
    Table 55. BioCryst Pharmaceuticals Inc Business Overview
    Table 56. BioCryst Pharmaceuticals Inc Marburgvirus Infection Product
    Table 57. BioCryst Pharmaceuticals Inc Revenue in Marburgvirus Infection Business (2018-2023) & (US$ Million)
    Table 58. BioCryst Pharmaceuticals Inc Recent Development
    Table 59. Eisai Co Ltd Company Detail
    Table 60. Eisai Co Ltd Business Overview
    Table 61. Eisai Co Ltd Marburgvirus Infection Product
    Table 62. Eisai Co Ltd Revenue in Marburgvirus Infection Business (2018-2023) & (US$ Million)
    Table 63. Eisai Co Ltd Recent Development
    Table 64. Emergent BioSolutions Inc Company Detail
    Table 65. Emergent BioSolutions Inc Business Overview
    Table 66. Emergent BioSolutions Inc Marburgvirus Infection Product
    Table 67. Emergent BioSolutions Inc Revenue in Marburgvirus Infection Business (2018-2023) & (US$ Million)
    Table 68. Emergent BioSolutions Inc Recent Development
    Table 69. Fab'entech SA Company Detail
    Table 70. Fab'entech SA Business Overview
    Table 71. Fab'entech SA Marburgvirus Infection Product
    Table 72. Fab'entech SA Revenue in Marburgvirus Infection Business (2018-2023) & (US$ Million)
    Table 73. Fab'entech SA Recent Development
    Table 74. Integrated BioTherapeutics Inc Company Detail
    Table 75. Integrated BioTherapeutics Inc Business Overview
    Table 76. Integrated BioTherapeutics Inc Marburgvirus Infection Product
    Table 77. Integrated BioTherapeutics Inc Revenue in Marburgvirus Infection Business (2018-2023) & (US$ Million)
    Table 78. Integrated BioTherapeutics Inc Recent Development
    Table 79. Johnson & Johnson Company Detail
    Table 80. Johnson & Johnson Business Overview
    Table 81. Johnson & Johnson Marburgvirus Infection Product
    Table 82. Johnson & Johnson Revenue in Marburgvirus Infection Business (2018-2023) & (US$ Million)
    Table 83. Johnson & Johnson Recent Development
    Table 84. NanoViricides Inc Company Detail
    Table 85. NanoViricides Inc Business Overview
    Table 86. NanoViricides Inc Marburgvirus Infection Product
    Table 87. NanoViricides Inc Revenue in Marburgvirus Infection Business (2018-2023) & (US$ Million)
    Table 88. NanoViricides Inc Recent Development
    Table 89. Profectus BioSciences Inc Company Detail
    Table 90. Profectus BioSciences Inc Business Overview
    Table 91. Profectus BioSciences Inc Marburgvirus Infection Product
    Table 92. Profectus BioSciences Inc Revenue in Marburgvirus Infection Business (2018-2023) & (US$ Million)
    Table 93. Profectus BioSciences Inc Recent Development
    Table 94. Rodos BioTarget GmbH Company Detail
    Table 95. Rodos BioTarget GmbH Business Overview
    Table 96. Rodos BioTarget GmbH Marburgvirus Infection Product
    Table 97. Rodos BioTarget GmbH Revenue in Marburgvirus Infection Business (2018-2023) & (US$ Million)
    Table 98. Rodos BioTarget GmbH Recent Development
    Table 99. Sarepta Therapeutics Inc Company Detail
    Table 100. Sarepta Therapeutics Inc Business Overview
    Table 101. Sarepta Therapeutics Inc Marburgvirus Infection Product
    Table 102. Sarepta Therapeutics Inc Revenue in Marburgvirus Infection Business (2018-2023) & (US$ Million)
    Table 103. Sarepta Therapeutics Inc Recent Development
    Table 104. Theravectys SA Company Detail
    Table 105. Theravectys SA Business Overview
    Table 106. Theravectys SA Marburgvirus Infection Product
    Table 107. Theravectys SA Revenue in Marburgvirus Infection Business (2018-2023) & (US$ Million)
    Table 108. Theravectys SA Recent Development
    Table 109. Research Programs/Design for This Report
    Table 110. Key Data Information from Secondary Sources
    Table 111. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Marburgvirus Infection Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Marburgvirus Infection Market Share by Type: 2022 VS 2029
    Figure 3. Eritoran Tetrasodium Features
    Figure 4. AR-12 Features
    Figure 5. ARD-5 Features
    Figure 6. AVI-7288 Features
    Figure 7. Others Features
    Figure 8. Global Marburgvirus Infection Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 9. Global Marburgvirus Infection Market Share by Application: 2022 VS 2029
    Figure 10. Hospital Case Studies
    Figure 11. Clinic Case Studies
    Figure 12. Others Case Studies
    Figure 13. Marburgvirus Infection Report Years Considered
    Figure 14. Global Marburgvirus Infection Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 15. Global Marburgvirus Infection Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 16. Global Marburgvirus Infection Market Share by Region: 2022 VS 2029
    Figure 17. Global Marburgvirus Infection Market Share by Players in 2022
    Figure 18. Global Top Marburgvirus Infection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Marburgvirus Infection as of 2022)
    Figure 19. The Top 10 and 5 Players Market Share by Marburgvirus Infection Revenue in 2022
    Figure 20. North America Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. North America Marburgvirus Infection Market Share by Country (2018-2029)
    Figure 22. United States Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Canada Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Europe Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Europe Marburgvirus Infection Market Share by Country (2018-2029)
    Figure 26. Germany Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. France Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. U.K. Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Italy Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Russia Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Nordic Countries Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Asia-Pacific Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Asia-Pacific Marburgvirus Infection Market Share by Region (2018-2029)
    Figure 34. China Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Japan Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. South Korea Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Southeast Asia Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. India Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Australia Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Latin America Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Latin America Marburgvirus Infection Market Share by Country (2018-2029)
    Figure 42. Mexico Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Brazil Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Middle East & Africa Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Middle East & Africa Marburgvirus Infection Market Share by Country (2018-2029)
    Figure 46. Turkey Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Saudi Arabia Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Arno Therapeutics Inc Revenue Growth Rate in Marburgvirus Infection Business (2018-2023)
    Figure 49. BioCryst Pharmaceuticals Inc Revenue Growth Rate in Marburgvirus Infection Business (2018-2023)
    Figure 50. Eisai Co Ltd Revenue Growth Rate in Marburgvirus Infection Business (2018-2023)
    Figure 51. Emergent BioSolutions Inc Revenue Growth Rate in Marburgvirus Infection Business (2018-2023)
    Figure 52. Fab'entech SA Revenue Growth Rate in Marburgvirus Infection Business (2018-2023)
    Figure 53. Integrated BioTherapeutics Inc Revenue Growth Rate in Marburgvirus Infection Business (2018-2023)
    Figure 54. Johnson & Johnson Revenue Growth Rate in Marburgvirus Infection Business (2018-2023)
    Figure 55. NanoViricides Inc Revenue Growth Rate in Marburgvirus Infection Business (2018-2023)
    Figure 56. Profectus BioSciences Inc Revenue Growth Rate in Marburgvirus Infection Business (2018-2023)
    Figure 57. Rodos BioTarget GmbH Revenue Growth Rate in Marburgvirus Infection Business (2018-2023)
    Figure 58. Sarepta Therapeutics Inc Revenue Growth Rate in Marburgvirus Infection Business (2018-2023)
    Figure 59. Theravectys SA Revenue Growth Rate in Marburgvirus Infection Business (2018-2023)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Knee Cartilage Repair and Regeneration Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-11V8576
Wed Apr 26 00:00:00 UTC 2023

Add to Cart

Global Lab Rat Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-32N13905
Wed Apr 26 00:00:00 UTC 2023

Add to Cart

Global Breast Lesion Localization Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-17U1223
Wed Apr 26 00:00:00 UTC 2023

Add to Cart

Global DNA/RNA Extractor Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-35K9678
Wed Apr 26 00:00:00 UTC 2023

Add to Cart